In the on-treatment analysis, Wegovy users had a 57% lower risk of experiencing heart attack, stroke, or death, with 15 events reported among Wegovy patients compared to 39 events in the tirzepatide group during an average follow-up of just under four months
Clin Pharmacokinet 2015;54:121 [DOI] [PubMed] [Google Scholar] 148
10.2174/1381612824666180608101119 71 SikiricP.SeiwerthS.BrcicL.BlagaicA
Attanzio A, Frazzitta A, Cilla A, Livrea MA, Tesoriere L, Allegra M
When you arrive at the appointment, bring: A parent or legal guardian with valid ID The minors medical history summary A complete list of current medications and known allergies Any physician clearance documentation the provider requested in advance Knowing how old you have to get IV therapy is really just the beginning of the conversation